Sands Capital Management 13F holdings, Q1 2011
Holdings as of March 31, 2011 · filings on SEC EDGAR · latest filing →
Sands Capital Management disclosed 52 US equity positions worth $14.4bn in its Q1 2011 13F filing. The largest position was AMZN at 8.3% of the reported book, followed by CRM and AAPL. Against the Q4 2010 filing, it opened 6 new positions, added to 36 and reduced 6 among the top 50 holdings.
What did Sands Capital Management own in Q1 2011? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2010 |
|---|---|---|---|---|---|---|---|
| 1 | AMZN AMAZON.COM | Consumer Cyclical | 8.3% | $1.2bn | 6,621,709 | 1% | added |
| 2 | CRM SALESFORCE.COM | Technology | 7.8% | $1.1bn | 8,441,199 | 1% | added |
| 3 | AAPL APPLE | Technology | 7.0% | $1.0bn | 2,921,395 | 1% | added |
| 4 | QCOM QUALCOMM | Technology | 7.0% | $1.0bn | 18,418,143 | -8% | reduced |
| 5 | V VISA INC | Financial Services | 6.5% | $942.6m | 12,803,530 | 20% | added |
| 6 | SLB SCHLUMBERGER | Energy | 5.3% | $765.9m | 8,212,528 | 4% | added |
| 7 | NATIONAL OILWELL VARCO | 5.1% | $736.5m | 9,291,577 | 0% | held | |
| 8 | 5.1% | $733.1m | 1,249,350 | 1% | added | ||
| 9 | ILMN ILLUMINA INC | Healthcare | 4.5% | $644.6m | 9,199,239 | 2% | added |
| 10 | ALLERGAN | 4.2% | $601.4m | 8,468,422 | 1% | added | |
| 11 | FMC TECHNOLOGIES | 3.6% | $514.8m | 5,448,330 | -28% | reduced | |
| 12 | INTERCONTINENTAL EXCHANGE | 3.4% | $493.7m | 3,996,149 | -4% | reduced | |
| 13 | SCHW CHARLES SCHWAB | Financial Services | 3.4% | $486.1m | 26,959,269 | 5% | added |
| 14 | NKE NIKE | Consumer Cyclical | 3.0% | $438.0m | 5,785,960 | 1% | added |
| 15 | FFIV F5 NETWORKS INC | Technology | 3.0% | $431.4m | 4,206,037 | 97% | added |
| 16 | ALXN ALEXION PHARMACEUTICALS INC | 2.9% | $419.7m | 4,252,862 | 2% | added | |
| 17 | VARIAN MEDICAL SYSTEMS | 2.8% | $407.9m | 6,030,053 | 1% | added | |
| 18 | ASML | 2.7% | $390.1m | 8,766,891 | 1% | added | |
| 19 | LVS LAS VEGAS SANDS | Consumer Cyclical | 2.7% | $383.4m | 9,080,207 | 1% | added |
| 20 | NFLX NETFLIX INC | Communication Services | 2.4% | $353.0m | 1,484,508 | 1% | added |
| 21 | GWW WW GRAINGER INC | Industrials | 2.4% | $344.1m | 2,499,612 | 1% | added |
| 22 | PXGBX PRAXAIR, INC | 2.2% | $313.4m | 3,084,370 | 1% | added | |
| 23 | SOUTHWESTERN ENERGY COMPANY | 2.0% | $285.2m | 6,637,589 | 1% | added | |
| 24 | CREE INC | 1.8% | $255.6m | 5,537,176 | -4% | reduced | |
| 25 | MELI MERCADOLIBRE | Consumer Cyclical | 0.2% | $35.7m | 437,550 | 2% | added |
| 26 | ABBNY ABB LTD | Industrials | 0.2% | $24.8m | 1,023,200 | 0% | held |
| 27 | MINDRAY MEDICAL INTL | 0.2% | $23.6m | 936,775 | 3% | added | |
| 28 | TSM TAIWAN SEMICONDUCTOR MFG ADS | Technology | 0.1% | $20.6m | 1,692,005 | -1% | reduced |
| 29 | ATHENAHEALTH, INC | 0.0% | $6.1m | 134,100 | 46% | added | |
| 30 | FLIR FLIR SYSTEMS INC | 0.0% | $5.0m | 143,840 | 22% | added | |
| 31 | ARM HOLDINGS PLC | 0.0% | $4.8m | 172,100 | 32% | added | |
| 32 | BMRN BIOMARIN PHARMS | Healthcare | 0.0% | $4.8m | 191,925 | 47% | added |
| 33 | NUVASIVE | 0.0% | $3.3m | 129,900 | 47% | added | |
| 34 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 0.0% | $3.0m | 34,870 | 31% | added |
| 35 | VECO VEECO INSTRUMENTS INC | Technology | 0.0% | $3.0m | 58,590 | -31% | reduced |
| 36 | NETSUITE INC | 0.0% | $2.3m | 79,700 | – | new | |
| 37 | CONCUR TECHNOLOGIES INC | 0.0% | $2.3m | 41,400 | – | new | |
| 38 | WEBMD HEALTH CORP | 0.0% | $2.3m | 42,325 | – | new | |
| 39 | DENDREON | 0.0% | $2.2m | 59,150 | 100% | added | |
| 40 | AKX ANSYS INC | 0.0% | $2.2m | 40,380 | – | new | |
| 41 | HUMAN GENOME SCIENCES | 0.0% | $1.7m | 63,475 | 48% | added | |
| 42 | CELG CELGENE | 0.0% | $1.7m | 28,750 | 3% | added | |
| 43 | VRTX VERTEX PHARMS | Healthcare | 0.0% | $1.6m | 33,875 | 49% | added |
| 44 | SEATTLE GENETICS INC | 0.0% | $1.5m | 94,925 | 44% | added | |
| 45 | NXSTAGE MEDICAL INC | 0.0% | $1.2m | 56,500 | – | new | |
| 46 | INCY INCYTE CORPORATION | Healthcare | 0.0% | $1.2m | 75,850 | 47% | added |
| 47 | VOLCANO CORP | 0.0% | $1.0m | 40,450 | – | new | |
| 48 | MNTA MOMENTA PHARMACEUTICALS INC | 0.0% | $774.0k | 48,825 | 48% | added | |
| 49 | ALIMERA SCIENCES INC | 0.0% | $648.0k | 83,025 | 46% | added | |
| 50 | VIVUS INC | 0.0% | $617.0k | 99,725 | 49% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.